Market Research Report
Malaria Treatment Market Forecast to 2027 - COVID-19 Impact and Global Analysis By Treatment Type (Vaccine, Antimalarial Agents, Diagnostic Test); Route of Administration (Oral, Parenteral); End User (Hospitals, Specialty Clinics, Others) and Geography
|Published by||The Insight Partners||Product code||990745|
|Published||Content info||172 Pages
Delivery time: 1-2 business days
|Malaria Treatment Market Forecast to 2027 - COVID-19 Impact and Global Analysis By Treatment Type (Vaccine, Antimalarial Agents, Diagnostic Test); Route of Administration (Oral, Parenteral); End User (Hospitals, Specialty Clinics, Others) and Geography|
|Published: January 27, 2021||Content info: 172 Pages||
The malaria treatment market was valued at US$ 1,508.12 million in 2019 and is projected to reach US$ 2,126.42 million by 2027; it is expected to grow at a CAGR of 4.4% from 2020 to 2027. High prevalence of malaria in low-income countries, and increasing initiatives undertaken by governments globally are among the major factors fueling the market growth. Moreover, increasing research for the development of new drugs and vaccines is expected to foster the market growth during the forecast period. However, increasing resistance to antimalarial drugs hinders the growth of the malaria treatment market. Additionally, the APAC countries are witnessing rise in demand for antimalarial drugs. Indian pharmaceutical companies had increased monthly production of anti-malarial drug Hydroxychloroquine (HCQ) four times to 40 metric tons (MT) and five to six times to over 70 metric tons (MT). The plan to step up production came after the Government of India indicated it would help countries in dire need of the drug to fight COVID-19.
The global malaria treatment market is segmented by treatment type, route of administration, and end user. Based on treatment type, the market is segmented into vaccine, diagnostic test, and antimalarial agents. The diagnostic test segment held the largest share of the market in 2019; whereas, the vaccine segment is anticipated to register the highest CAGR during the forecast period. Based on route of administration, the market is segmented into oral, and parenteral. The oral segment held a larger share of the market in 2019, and is anticipated to register the highest CAGR during the forecast period. Based on end user, the Malaria Treatment market is segmented into hospitals, specialty clinics, and others. The hospitals segment held the largest share of the market in 2019, and is anticipated to register the highest CAGR during the forecast period.
The World Health Organization (WHO), Centers for Disease Control and Prevention (CDC), and the United Nations Children's Fund (UNICEF) are among the primary and secondary sources referred while formulating this report.
Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the malaria treatment market.
Highlights key business priorities in order to assist companies to realign their business strategies.
The key findings and recommendations highlight crucial progressive industry trends in the global malaria treatment market, thereby allowing players across the value chain to develop effective long-term strategies.
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.